UNSPSC 51343506: Cidofovir anhydrous

This classification denotes an antiviral agent with the molecular formula C8H14N3O6P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 768M1V522C, chemically known as phosphonic acid, ((2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, (s)-, but more generally known as cidofovir anhydrous, which bears US NIH Compound Identifier 60613. European Medicines Agency schedules cidofovir anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06257MIG.

Most nations, for tariff purposes, schedule cidofovir anhydrous under HS 29335995. Cidofovir anhydrous bears US NLM identifiers UMLS ID C2699210 and NCI Concept Code C77925. SMILES: C1CN(C(=O)NC1N)C[C@@H](CO)OCP(=O)(O)O.

UNSPSC 51343506 Cidofovir anhydrous is a Commodity code for a specific antiviral pharmaceutical ingredient, but the recent state and local opportunities posted under this code do not reflect procurement of cidofovir itself. Instead, the tagged opportunities show state and local health agencies acquiring finished pharmaceutical products and medical supplies — antibiotic tablets, naloxone, and drug deactivation systems — through competitive bidding and cooperative purchasing vehicles. The mismatch between the code's nominal scope and actual procurement activity suggests either a cataloging error in the state or local systems or that cidofovir procurement is rare enough in state and local government to leave no recent matching opportunities in the dataset.

The two posted opportunities span different issuing bodies and procurement types: the Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC for $2,999,999.11 over 12 months with renewal options, with an IFB process yielding Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets; and Seminole County, Florida issued an IFB on June 30, 2026 with a response deadline of July 26, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, to be delivered quarterly to the county's community health building. The Illinois opportunity closed in September 2026, while the Seminole County posting shows a 2023 deadline that appears outdated in the source record. Without additional recent opportunities properly tagged to cidofovir procurement, the code shows minimal active demand in current state and local solicitations.